U.S. Wireless Telecom Stock News

Datavault AI Inc. has reported its full-year 2025 results, with revenue of US$39.09 million versus US$2.67 million a year earlier and a net loss of US$78.99 million compared with US$51.41 million, alongside basic and diluted loss per share from continuing operations of US$0.52 versus US$16.14 previously. Beyond the headline numbers, the earnings release caps a period of heightened attention on Datavault AI’s Tokenized Legacy platform and ADIO audio technology, which have been highlighted at...

GlobalFoundries (NasdaqGS:GFS) is expanding into silicon photonics, working with Flexcompute to link photonic device design tools directly to its manufacturing stack. The collaboration focuses on optical interconnects for AI data centers, aiming to streamline the path from simulation to fabrication. This move targets a growing market in data center optics while seeking to lower design and integration hurdles for customers. GLOBALFOUNDRIES, trading at $42.47, is drawing attention in advanced...

Considering whether Definium Therapeutics at around US$17.64 still offers value, or if most of the opportunity is already priced in. The stock has seen a 5.3% decline over the last 7 days, but sits on gains of 12.0% over 30 days, 29.3% year to date and 163.3% over 1 year, with a very large 3 year return that is more than 5x, although the 5 year return is a 54.3% decline. Recent market attention has been shaped by broader interest in high growth pharmaceutical and biotech names, where...

Artisan Partners has taken a new small cap position in Bruker (NasdaqGS:BRKR), citing confidence in the company’s acquisitions and product pipeline. The investment thesis points to anticipated easing of short term market headwinds as a support for future profit growth. Bruker’s share price stands at $34.03 after a period of pressure, with the stock down 7.6% over the past week and 6.8% over the past month. The drawdown is more extended over longer periods, with a 29.3% decline year to date...

Himax Technologies (NasdaqGS:HIMX) highlighted new AI powered modules and automotive display ICs at Embedded World 2026. The company showcased WiseEye, WiseGuard and PalmVein ultralow power AI solutions for smart home, security, automotive and drone uses. Rumors point to potential collaborations with major tech firms for smart glasses integration and AI data center applications. For you as an investor, this matters because Himax Technologies, long known for display driver ICs, is now...

Event driven move in PPL stock PPL (PPL) is back in focus after the company reported 2025 results, issued a 2026 EPS growth forecast, extended its annual EPS growth target through at least 2029, and outlined a US$23b infrastructure investment plan. See our latest analysis for PPL. At a share price of US$38.05, PPL has had a 9.5% 90 day share price return and a 12.2% 1 year total shareholder return, suggesting momentum has been building alongside its latest results and infrastructure plan. If...

Wondering if Sanmina's share price really reflects its underlying value, or if the recent run in the stock has left mispricing on the table. The stock closed at US$125.03, with returns of 59.8% over 1 year and 118.1% over 3 years, even as the share price has seen a 14.3% drop over 30 days and a 21.5% fall year to date. Recent coverage has focused on Sanmina's role in technology manufacturing and its positioning within the broader electronics supply chain, giving investors more information to...

Crane NXT (NYSE:CXT) has appointed technology and manufacturing executive Jeffrey Benck to its Board of Directors. Longtime director James L.L. Tullis will step down from the board after the upcoming Annual Meeting. The board change introduces new industry experience and marks the end of a lengthy period of service by Tullis. For investors tracking Crane NXT, the board shift comes at a time when the share price stands at $41.37, with the stock showing a 21.6% decline over the past 30 days...

In March 2026, Goosehead Insurance, Inc. filed a shelf registration for up to US$66.65 million, covering 1,510,000 common shares in an employee stock ownership plan (ESOP)-related offering. This ESOP-linked shelf registration highlights Goosehead’s emphasis on employee ownership, which can influence incentives, capital structure, and longer-term business alignment. We’ll now examine how this ESOP-related shelf registration could influence Goosehead Insurance’s investment narrative and its...

Wondering whether Upstart Holdings at around US$25.83 is starting to look like value or still carries more risk than reward? This article walks through the numbers to help you frame that question clearly. The stock has seen sharp swings, with returns of 6.0% decline over 7 days, 15.8% decline over 30 days, a 43.7% decline year to date, and a 49.4% decline over the last year, set against an 83.1% gain over three years and a 77.0% decline over five years. Recently, attention on Upstart has...

Skyward Specialty Insurance Group (SKWD) has drawn attention after recent trading saw the share price around $42.83, with returns weaker over the past month and the past 3 months compared with the prior 3 years. See our latest analysis for Skyward Specialty Insurance Group. For context, the 1 day share price return of a 4.9% decline and the 90 day share price return of a 17.3% decline sit against a 3 year total shareholder return of 120.1%. This suggests that recent momentum has cooled after...

In the past week, ResMed’s share price weakness has erased about US$3.30 billion from its market value, leaving the company at roughly US$34.00 billion despite reports that its operating performance and financial condition remain solid. This disconnect between market sentiment and underlying business health raises questions about whether recent trading reflects short-term emotion rather than changes in ResMed’s long-term outlook. Against this backdrop of recent market value erosion despite...

Wondering whether Fortune Brands Innovations at around US$41.35 is starting to look like value or still has more risk priced in? This article walks through the key signals to help you frame that question. The stock has seen a 8.5% decline over the last 7 days, a 19.4% decline over the last 30 days, and is tracking 18.8% lower year to date, with a 33.6% decline over the last 12 months and longer term 24.0% and 41.0% declines over 3 and 5 years respectively. These moves have attracted...

SLB OneSubsea secured a contract with China National Offshore Oil Corporation for the deepwater Kaiping 18-1 field development in China. SLB reported its digital annual recurring revenue has moved above $1 billion. The company announced a dividend increase, signaling a change in shareholder return policy. NYSE: SLB trades at $45.32, with the share price up 12.7% year to date and 84.2% over the past five years. Over the shorter term, the stock has seen a 5.9% decline over the past week and a...

Wondering whether Ciena's share price still offers value after such a strong run, or if it is getting ahead of itself? This article breaks down what the current price may be implying. Ciena's stock recently closed at US$385.26, with stated returns of 13.3% over 7 days, 26.8% over 30 days and 56.6% year to date, and a very large 1 year gain that is close to 7x along with substantial multi year returns. Recent market attention on Ciena has been driven by ongoing interest in communications and...

If you are wondering whether Axcelis Technologies is attractively priced right now, the key question is how its current share price stacks up against its underlying fundamentals. The stock closed at US$85.74, with returns of a 0.6% decline over 7 days, a 9.3% decline over 30 days, a 0.4% decline year to date, a 49.4% gain over 1 year, a 34.8% decline over 3 years, and a 135.5% gain over 5 years. This performance can change how you think about both risk and opportunity. Recent news flow...

Event context and recent stock performance New Jersey Resources (NJR) has been drawing investor attention following its recent share price moves, with the stock last closing at $53.28 as returns over the past month and past 3 months diverge. See our latest analysis for New Jersey Resources. While the 1 day and 1 month share price returns of 1.75% sit in negative territory, the 90 day share price return of 11.58% and 1 year total shareholder return of 12.46% suggest that momentum has been...

Event driven snapshot: what stands out in ReNew Energy Global (NasdaqGS:RNW) now ReNew Energy Global (NasdaqGS:RNW) is back on investors’ radar after recent share price weakness, with the stock down 2.6% over the past week and 6.5% over the past 3 months. That move comes against the backdrop of a market value of about US$1.9b and annual revenue of ₹129,449, supported by net income of ₹12,113 and a value score of 4 that may interest valuation focused investors. See our latest analysis for...

If you are wondering whether Maximus shares are now offering value or still look fully priced, the recent share performance gives you some useful clues. The stock last closed at US$69.11, with returns of 2.2% over 1 year but declines of 6.3% over 7 days, 7.5% over 30 days, and 20.1% year to date. Recent headlines have focused on Maximus as a key contractor in government services, including ongoing work in areas such as health and human services administration. This keeps attention on the...

Wondering if Globe Life at around US$137.62 is pricing in too much optimism or too much caution? This article walks through what that share price could imply about value. The stock has seen mixed recent returns, with a 2.4% decline over the last 7 days and a 4.6% decline over the last 30 days, while still showing 8.9% over 1 year, 31.9% over 3 years and 48.5% over 5 years. These moves are playing out against a backdrop of ongoing attention on US insurers, including Globe Life, as investors...

If you are wondering whether CorMedix at around US$6.37 is a bargain or a value trap, the next sections are going to focus squarely on what the numbers suggest about its current price. The stock has seen sharp swings, with a 4.8% decline over the last week, a 13.2% decline over the last month, a 47.6% decline year to date, a 41.9% decline over the past year, but a 97.8% gain over three years that still leaves five year returns at a 26.8% decline. These moves have put valuation firmly in...

NRG Energy (NYSE:NRG) has partnered with Equilibrium Energy to deploy the AI native PowerOS platform for portfolio optimization. This is the first public application of PowerOS within NRG’s operations. The rollout is aimed at bringing enterprise level AI tools into NRG’s decision making and operational processes. NRG Energy, trading at $159.11, has seen a very large 3 year return and a 1 year return of 63.9%, with a 7.1% gain over the past week. Recent Simply Wall St coverage has focused on...

Shareholders at NYSE:NVR have filed multiple proposals ahead of the upcoming annual meeting. The proposals seek enhanced disclosure of greenhouse gas emissions and stronger shareholder rights to call special meetings. NVR’s board has recommended voting against both items, putting governance and sustainability practices under closer investor scrutiny. NVR, which last closed at $6,482.82, is coming into the meeting with a mixed recent track record, including a 19.5% return over 3 years and...

Lantheus Holdings (LNTH) shares are in focus after the FDA approved PYLARIFY TruVu, a new formulation of its PSMA PET imaging agent for prostate cancer, highlighting potential implications for manufacturing efficiency and product reach. See our latest analysis for Lantheus Holdings. The FDA approval of PYLARIFY TruVu arrives alongside a 30 day share price return of 15.65% and a 90 day share price return of 23.75%, yet the 1 year total shareholder return is a 22.31% decline, indicating that...